Rituximab News and Research

RSS
Rituximab is approved by the Food and Drug Administration (FDA) to be used alone or with other drugs to treat certain types of B-cell non-Hodgkin lymphoma. It is also approved to be used with methotrexate to treat rheumatoid arthritis. Rituximab is also being studied in the treatment of other types of cancer and other conditions.
Light-Activated Macrophages Show Increased Appetite for Cancer Cells

Light-Activated Macrophages Show Increased Appetite for Cancer Cells

Key discovery could prevent treatment failure in people with severe hemophilia A

Key discovery could prevent treatment failure in people with severe hemophilia A

New analysis technique could pave way for major breakthroughs in immunotherapy

New analysis technique could pave way for major breakthroughs in immunotherapy

New radioimmunotherapy effectively reverses resistance to lymphoma therapy

New radioimmunotherapy effectively reverses resistance to lymphoma therapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.